Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.94%23.88B | 4.25%132.31B | 6.27%24.6B | 10.30%126.91B | 13.32%32.08B | 5.55%43.74B | 15.43%27.95B | 9.72%23.15B | 17.12%115.05B | 15.76%28.31B |
| Cost of revenue | -7.70%11.23B | 6.10%63.38B | 6.36%12.17B | 8.58%59.73B | 7.25%15.47B | 4.69%19.13B | 10.95%13.7B | 14.68%11.44B | 18.34%55.02B | 16.75%14.43B |
| Gross profit | 1.71%12.65B | 2.61%68.93B | 6.17%12.43B | 11.89%67.17B | 19.63%16.6B | 6.22%24.61B | 20.09%14.25B | 5.29%11.71B | 16.03%60.04B | 14.74%13.88B |
| Operating expense | -0.25%10.57B | 8.53%47.02B | 12.15%10.59B | 13.63%43.33B | 16.47%11.95B | 13.08%11.49B | 17.92%10.44B | 6.67%9.45B | 8.20%38.13B | 5.17%10.26B |
| Operating profit | 13.05%2.08B | -8.14%21.91B | -18.77%1.84B | 8.87%23.85B | 28.57%4.66B | 0.87%13.12B | 26.48%3.81B | -0.13%2.26B | 32.74%21.91B | 54.56%3.62B |
| Net non-operating interest income (expenses) | -133.33%-7M | -6M | 40.00%-3M | 0 | 40.00%14M | 50.00%-3M | 40.00%-6M | 37.50%-5M | 75.86%-14M | 900.00%10M |
| Non-operating interest income | 50.00%6M | -11.11%32M | 0.00%4M | 28.57%36M | 15.00%23M | 25.00%5M | 33.33%4M | 300.00%4M | 12.00%28M | 11.11%20M |
| Non-operating interest expense | 85.71%13M | 5.56%38M | -22.22%7M | -14.29%36M | -10.00%9M | -20.00%8M | -23.08%10M | 0.00%9M | -49.40%42M | -41.18%10M |
| Net investment income | -23.64%42M | 22.09%105M | 5.77%55M | 26.47%86M | 0.00%1M | 19.23%31M | 2M | 26.83%52M | 15.25%68M | 0.00%1M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 123M | -493.75%-1.45B | 0 | 584.21%368M | -28.40%-104M | 0 | 491M | -480.00%-19M | -249.02%-76M | -325.00%-81M |
| Income from associates and other participating interests | -30.34%1.63B | -0.37%8.45B | 27.87%2.34B | 43.90%8.48B | 77.29%4.22B | -13.05%1.25B | 18.50%1.19B | 69.44%1.83B | 60.56%5.89B | -0.21%2.38B |
| Special income (charges) | 0 | 301.91%846M | -119.05%-46M | -150.90%-419M | -201.52%-398M | 0 | 0 | -126.58%-21M | 26.43%-167M | 31.96%-132M |
| Less:Other special charges | ---- | -359.54%-1.01B | 119.05%46M | 165.75%388M | 230.63%367M | --0 | --0 | 126.58%21M | 210.64%146M | 692.86%111M |
| Less:Write off | ---- | 419.35%161M | ---- | 47.62%31M | ---- | ---- | ---- | ---- | -88.33%21M | ---- |
| Other non-operating income (expenses) | -65.91%15M | 90.36%375M | 41.94%44M | -31.83%197M | -26.42%142M | -81.25%3M | -76.92%21M | 381.82%31M | 110.95%289M | 85.58%193M |
| Income before tax | -8.07%3.88B | -7.17%30.22B | 2.23%4.22B | 16.71%32.55B | 42.36%8.53B | -0.51%14.4B | 38.13%5.5B | 19.67%4.13B | 38.55%27.89B | 28.13%5.99B |
| Income tax | 22.56%679M | -29.73%5.77B | -28.70%554M | 19.57%8.2B | 42.28%1.8B | 2.31%4.13B | 107.88%1.5B | -7.61%777M | 20.01%6.86B | 13.58%1.26B |
| Net income | -12.73%3.2B | 0.43%24.45B | 9.42%3.67B | 15.77%24.35B | 42.36%6.73B | -1.60%10.27B | 22.68%4B | 28.47%3.35B | 45.91%21.03B | 32.72%4.73B |
| Net income continuous operations | -12.70%3.2B | 0.43%24.45B | 9.39%3.67B | 15.77%24.35B | 42.38%6.73B | -1.60%10.27B | 22.65%4B | 28.46%3.35B | 45.91%21.03B | 32.68%4.73B |
| Noncontrolling interests | 62.50%13M | -87.88%8M | 60.00%8M | 26.92%66M | 31.25%21M | 50.00%18M | 22.22%22M | -16.67%5M | -16.13%52M | 16M |
| Net income attributable to the company | -12.87%3.19B | 0.67%24.44B | 9.35%3.66B | 15.75%24.28B | 42.43%6.71B | -1.66%10.25B | 22.68%3.98B | 28.58%3.35B | 46.18%20.98B | 32.24%4.71B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -12.87%3.19B | 0.67%24.44B | 9.35%3.66B | 15.75%24.28B | 42.43%6.71B | -1.66%10.25B | 22.68%3.98B | 28.58%3.35B | 46.18%20.98B | 32.24%4.71B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -14.09%23.33 | 1.28%181.99 | 9.65%27.1567 | 15.76%179.6967 | 42.74%49.7533 | -1.76%75.7833 | 22.54%29.3933 | 28.68%24.7667 | 47.23%155.23 | 33.14%34.8567 |
| Diluted earnings per share | -14.09%23.33 | 1.28%181.99 | 9.65%27.1567 | 15.76%179.6967 | 42.77%49.7533 | -1.76%75.7833 | 22.54%29.3933 | 28.68%24.7667 | 47.23%155.23 | 33.11%34.848 |
| Dividend per share | 0 | 7.24%54.3333 | 0 | 38.18%50.6667 | 43.53%40.6667 | 0 | 20.00%10 | 0 | 29.41%36.6667 | 30.77%28.3333 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |